|
Volumn 354, Issue 25, 2006, Pages 2637-2641
|
ADHD in adults
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHETAMINE;
ATOMOXETINE;
CENTRAL STIMULANT AGENT;
DEXAMPHETAMINE;
DEXMETHYLPHENIDATE;
METHAMPHETAMINE;
METHYLPHENIDATE;
MODAFINIL;
PEMOLINE;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
BRAIN MATURATION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL ASSESSMENT;
DIASTOLIC BLOOD PRESSURE;
DRUG SAFETY;
DRUG USE;
ENVIRONMENTAL FACTOR;
GEOGRAPHIC DISTRIBUTION;
HUMAN;
LONG TERM CARE;
MEDICAL PRACTICE;
MEDICAL SOCIETY;
MEDICAL STUDENT;
PATIENT SATISFACTION;
PHYSICIAN;
PRESCRIPTION;
PRIORITY JOURNAL;
RATING SCALE;
RESIDENCY EDUCATION;
REVIEW;
RISK FACTOR;
SMOKING CESSATION;
SYMPTOMATOLOGY;
SYSTOLIC BLOOD PRESSURE;
UNITED STATES;
ADULT;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CENTRAL NERVOUS SYSTEM STIMULANTS;
DIAGNOSIS, DIFFERENTIAL;
DIAGNOSTIC ERRORS;
EUROPE;
HUMANS;
PREVALENCE;
PSYCHOTHERAPY;
UNITED STATES;
|
EID: 33745255383
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp068113 Document Type: Review |
Times cited : (66)
|
References (6)
|